T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option ...
Morning Overview on MSN
Deadly brain cancer with no cure may finally have a kill switch
Glioblastoma is the diagnosis that neuro-oncologists dread and patients fear, a fast-growing brain cancer that resists surgery, radiation, and chemotherapy and almost always returns. For decades, the ...
In a recent study, researchers manipulated cellular proteins that control genes in aged mice. Experimental results showed their livers were rejuvenated to younger states. This work shows promise as a ...
Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.
A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.
Factinate on MSN
Humans are born with tails but lose them before birth, and scientists still don’t know why we have them at all
Early in pregnancy, something surprising happens. Every human embryo develops a tail. It is not symbolic or imagined. A real ...
Study Highlights the Efficacy of PMC in Suppressing Non-Small Cell Lung Cancer Growth SEOUL, SOUTH KOREA, January 23, 2026 ...
Cells operate on rules not vibes, including when on the precipice of persisting or perishing. Yet, with prior research ...
The structural and functional characteristics of mitochondria shape their role as signaling organelles, with far-reaching ...
With a 5-year survival of only 3.3% in advanced disease, pancreatic cancer remains one of the most lethal human tumors. But ...
A new study published in Pharmaceuticals and conducted by researchers from McGill University sheds light on how cannabidiol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results